|
May 2
|
Quest to ramp up AI capabilities with purchase of PathAI’s diagnostic lab
|
|
May 1
|
Quest Diagnostics to Acquire PathAI Diagnostics to Accelerate AI and Digital Pathology Adoption in Cancer Diagnosis; Forms Licensing Agreements with PathAI
|
|
Apr 26
|
Quest Diagnostics Foundation and Green Bronx Machine Expand Collaboration to Bring Acclaimed Indoor Gardening Curriculum to More Communities and Raise Awareness for Impact of Nutrition Education on Health Equity
|
|
Apr 26
|
Quest Diagnostics Incorporated Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions
|
|
Apr 26
|
Decoding Quest Diagnostics Inc (DGX): A Strategic SWOT Insight
|
|
Apr 25
|
Quest Diagnostics Incorporated (NYSE:DGX) Q1 2024 Earnings Call Transcript
|
|
Apr 24
|
Is Now The Time To Look At Buying Quest Diagnostics Incorporated (NYSE:DGX)?
|
|
Apr 24
|
Quest Diagnostics First Quarter 2024 Earnings: Beats Expectations
|
|
Apr 24
|
Quest Diagnostics Inc (DGX) Q1 2024 Earnings Call Transcript Highlights: Key Financial Outcomes ...
|
|
Apr 24
|
Q1 2024 Quest Diagnostics Inc Earnings Call
|
|
Apr 23
|
Quest Diagnostics Q1 2024 Earnings: Aligns with Analyst EPS Projections, Raises Full-Year Guidance
|
|
Apr 23
|
Quest Diagnostics Reports First Quarter 2024 Financial Results; Raises Guidance for Full Year 2024
|
|
Apr 22
|
Unlocking Q1 Potential of Quest Diagnostics (DGX): Exploring Wall Street Estimates for Key Metrics
|
|
Apr 22
|
Quest Diagnostics Adds p-tau217 Blood Biomarker Testing to Suite of Services Designed to Assess Risk and Help Aid Diagnosis of Alzheimer's Disease
|
|
Apr 16
|
Earnings Preview: Quest Diagnostics (DGX) Q1 Earnings Expected to Decline
|
|
Apr 15
|
Quest Diagnostics (DGX) to Post Q1 Earnings: What's in Store?
|
|
Apr 15
|
Q4HE Initiative Recognized for Efforts To Reduce Health Disparities
|
|
Apr 11
|
Myriad Genetics (MYGN) Announces Favorable Research Results
|
|
Apr 9
|
My Quest Story - Jessica Clow
|
|
Apr 5
|
Quest Diagnostics' (NYSE:DGX) investors will be pleased with their respectable 62% return over the last five years
|